Reports indicate anticancer activity with higher blood levels of CoQ 10 (reduced risk of melanoma development, recurrence and progression.) Why do we rarely hear about this? Very few human studies have been conducted to confirm these findings. (imagine that…no profit potential…no money to conduct this study)

What is CoQ 10?

CoQ 10 (also known as: coenzyme Q10, Q10, Vitamin Q10, Ubiquinone, Ubiquinol, Ubidecarenone) is an important protein made by the body, that is involved in cellular metabolism (converting the energy from fats and sugars into usable cellular energy) and as a protective antioxidant.

CoQ 10 stimulates the immune system

Numerous studies have reported on the immune stimulating effects of CoQ 10, although the mechanisms involved in this physiologic activity are not known.

http://www.ncbi.nlm.nih.gov/pubmed/1673841?dopt=Abstract

http://www.ncbi.nlm.nih.gov/pubmed/10416052?dopt=Abstract

http://www.ncbi.nlm.nih.gov/pubmed/101414?dopt=Abstract

http://www.ncbi.nlm.nih.gov/pubmed/5478631?dopt=Abstract

CoQ 10 can suppress cancer cell growth

The mechanisms involved in this anticancer activity are not known.

http://www.ncbi.nlm.nih.gov/pubmed/4218125?dopt=Abstract

http://www.ncbi.nlm.nih.gov/pubmed/653103?dopt=Abstract

CoQ 10 protects the heart from chemotherapy injury

Studies have demonstrated that CoQ 10 can protect heart tissue from the potentially damaging effects of a commonly used class of chemotherapy drugs, called anthracyclines (i.e. doxorubicin).

CoQ 10 blood levels correlate with the risk of developing melanoma

Researchers prospectively followed 117 early stage (none with metastatic disease) melanoma patients and 125 healthy volunteers (control group), and they discovered some remarkable differences. First, the CoQ 10 levels were significantly lower in patients than in control group. Second, those with CoQ 10 levels less than 0.6 mg/L (low) had a 790% increased risk of developing metastatic disease compared with those patients who had higher levels of CoQ 10; the time to develop metastases was also almost double in patients with CoQ 10 levels 0.6 mg/L or higher! Among the 82 melanoma patients with a low CoQ 10 level (less than 0.6 mg/L), 17 of them died during the study period…whereas, none of the patients with higher CoQ 10 levels died.

http://www.ncbi.nlm.nih.gov/pubmed/16443053

CoQ 10 has been reported to enhance the efficacy of interferon therapy for melanoma

One of the standard therapies for use in patients with advanced stages of melanoma (stages 3-4) is an immune stimulating agent, interferon (IFN). IFN stimulates the immune system to recognize and attack melanoma cells. Patients with early stage disease (stages 1-2) are not typically recommended to receive IFN after surgery, as this drug is difficult for many patients to tolerate due to various side effects and the potential benefit in reducing the risk of recurrence has not well-established in these early stages.

One enterprising group of oncologists postulated that by giving CoQ 10 to those with early stage melanoma, they might be able to further stimulate the immune system. What they found was incredible:

In their study, they gave 32 patients with early stage (stage 1-2) melanoma IFN (2 injections per day of 600,000 IU) plus 400mg per day of CoQ10 for 3 years after surgery, while 49 received only interferon. The patients were monitored for five years after their treatment ended. They reported that the patients who received the IFN + CoQ10 had a reduction in their risk of developing metastases by 10-times compared with those who received only IFN. Furthermore, the IFN + CoQ 10 patients had far fewer IFN-related side effects compared with the IFN only patients; 22% versus 82%, respectively.

Other cancers that might benefit from CoQ 10 supplementation:

Very small studies and case reports have suggested that CoQ 10 may help some cancer patients live longer, including patients with cancers of the breast, pancreas, lung, colon, rectum, and prostate. Although these reports are promising, they are unfortunately not high-quality studies, therefore not much weight can be placed on these results.

Note of caution…don’t take CoQ 10 during radiation therapy:

A mouse study demonstrated reduced anticancer activity of radiation therapy when supplemented with CoQ 10. Radiation therapy works by creating free radicals in cancer cells, which then interact with the DNA and cause cell death. It is believed that by supplementing with a potent antioxidant, such as CoQ 10, the free radicals created by radiation therapy will be diminished along with its’ anticancer efficacy. Read my review article on this in the Journal of the National Cancer Institute.

CoQ 10 side effects:

None-to-mild side effects, including mild insomnia, elevated liver enzymes, rashes, nausea, upper abdominal pain/heartburn, dizziness, sensitivity to light, irritability, headache, and fatigue.

Commonly prescribed medications can lower CoQ 10 levels:

Lipid lowering medications (such as lovastatin, pravastatin, simvastatin, gemfibrozil) and the oral diabetes medications (such as glyburide and tolazamide) are well-known to reduce CoQ 10 levels. Patients taking these medications should discuss with their primary care physician supplementation with CoQ 10.

Cautionary effects of CoQ 10:

CoQ 10 may reduce the efficacy of warfarin.

CoQ 10 may reduce insulin requirements in diabetics.

As CoQ 10 has not been exhaustively researched with every chemotherapy agent or combination of agents (it’s never going to happen), recognize that there is a possibility of interactions that can either increase or decrease the anticancer effectiveness of the chemotherapy agent. Always discuss any use of supplements with your oncology team prior to using them.

Dosing:

There are no established dosing guidelines. In human studies, supplementation doses and administration schedules have varied, but usually have been in the range of 90 to 390 mg/day (most common recommendation: 100-200 mg/day)

Most absorbable form of CoQ 10:

Ubiquinol absorbs up to 8 times greater than ubiquinone, and higher levels of ubiquinol remain in the blood far longer than ubiquinone.

CoQ 10 is fat soluble. It is more effectively absorbed when taken with a meal (particularly with lipids).

Additional Resources:

National Cancer Institute PDQ: CoQ 10

About Herbs, Botanicals and Other Products (Memorial Sloan-Kettering Cancer Center): CoQ 10

Wikipedia; CoQ 10

Medline Plus (National Library of Medicine): CoQ 10 

CoQ 10 and Cancer Treatment (Life Extension)**although I like many of their products, this is still a supplement company**

 

Become a FAN to follow us on Facebook

Share
 
Amazing anti-cancer compound derived from the French Lilac: Galega officianalis (metformin)

Metformin is a medication derived from the herb Galega officinalis (French lilac, also known as Goat’s Rue or Italian Fitch) and has been used as a traditional botanical (tea infusion) for over 3,000 years to relieve polyuria (frequent urination) and halitosis (sweet odor on the breath), both are now well known symptoms of diabetes. Approved for the treatment of hyperglycemia in Britain since the late 1950′s, Canada in the 1970′s and U.S. in 1995, metformin is the most widely prescribed diabetes drugs (over 120 million prescriptions filled yearly worldwide). Although the mechanism of action of metformin in diabetes is only partially understood, metformin treatment [...read more...]

Share
 
Smoking increases the risk of prostate cancer recurrence and death

One of the most important studies I have read on prostate cancer was published earlier this week in the Journal of the American Medical Association. Researchers at the Harvard School of Public Health investigated the possible effects of smoking and prostate cancer. They followed a group of over 5,300 men for an average of 8 years after being diagnosed with prostate cancer. They found something VERY surprising. Men who continued to smoke after their diagnosis of prostate cancer (compared to either men who never smoked or who quit 10+ years before their diagnosis) had much worse outcomes. They had: a [...read more...]

Share
 
Fight weight loss (and potentially improve survival) during cancer therapy using a fish oil supplement

The conclusions of two studies published in 2011, in the journal Cancer, suggest that the use of a fish oil supplement taken during treatment for cancer can help patients maintain their weight (**and improves the efficacy of chemotherapy**) The first study examined the use of a fish oil supplement (2.5 grams of EPA + DHA/day) in patients undergoing first-line chemotherapy for non-small cell lung cancer. The control group of patients only received chemotherapy. The authors found at one year: A significant improvement in the response rate to the chemotherapy in those patients that received the fish oil supplement versus the [...read more...]

Share
 
Lung cancer eradicated in 98% of patients with a rapid, 3 to 5-day course of radiation therapy: A new paradigm in the management of early stage lung cancer.

A recently reported study (in the Journal of the American Medical Association, 2010) demonstrated the remarkable effectiveness of the latest radiation therapy technique (called “stereotactic body radiation therapy” or “SBRT”) in the treatment of early stage lung cancers (stage 1, T1-2N0M0, non-small cell carcinoma.) The study authors (Radiation Therapy Oncology Group), reported a 97.6% local tumor control rate, 3 years after a 3-day course of SBRT (3 doses of 20 Gy). These excellent results are comparable to those achievable by surgery, but SBRT has the advantage of being a non-invasive treatment. A course of SBRT frequently involves 3-5 daily doses of external beam radiation. [...read more...]

Share
 
One "baby aspirin" per day cuts cancer death risk by up to 60%

A study (published in the journal, Lancet, December 2010) reports that compared with placebo, taking 75 mg of aspirin per day (one baby aspirin=81 mg) for 4 years or more reduced the risk of dying from a variety of common cancers.  These results were identified through a meta-analysis of 8 placebo-controlled randomized trials (comparing placebo vs. aspirin), in 25,570 patients. These studies were designed to explore the long-term effects of aspirin. They found the following risk reduction in cancer deaths: prostate cancer (10% risk reduction) lung cancer (30% risk reduction) colon, rectal, pancreatic, and stomach cancers (40% risk reduction) esophageal [...read more...]

Share
 
It's never too late to quit!! Smoking cessation after a lung cancer diagnosis can DOUBLE the survival rate

Although the following paper was published already 7 months ago (January 2010, in the British Medical Journal),  and is no longer new news, I strongly feel that the information needs to be reinforced. The authors conducted a review of 10 high-quality studies that evaluated the potential influence on survival in patients with lung cancer who quit smoking after their diagnosis. Most of the studies (9 out of 10) looked only at the effects of smoking in cessation in patients with early stage lung cancers. What they found was quite remarkable: survival rates doubled among those patients who quit smoking after their [...read more...]

Share
 
Shark cartilage is NOT an effective cancer treatment- stop killing sharks for their fins!

An excellent study (published in May 2010, in the Journal of the National Cancer Institute) demonstrates that shark cartilage is NOT an effective treatment for cancer. This study was conducted to evaluate the potential survival benefit of adding a pharmacologic-grade shark fin supplement to a conventional treatment regimen (chemotherapy and radiation therapy) in individuals with lung cancer. Sharks fins have been used as a cancer treatment (mainly in Asia) with the presumption that since sharks don’t develop cancer (this is actually not true- sharks do develop cancer), they must have an ‘anti-cancer’ substance within their tissues. In the current study, [...read more...]

Share
 
Eat your broccoli: anti-cancer phytonutrients reduce the development and growth of breast cancer cells and tumors

In a study (published in May 2010, in Clinical Cancer Research) investigators have discovered that a natural compound found in broccoli, called sulforaphane, was able to significantly decrease the number of breast cancer stem cells (the earliest cancer cells that form tumors) in cell preparation studies and in mouse studies. The authors used a highly concentrated form of this natural compound, derived from broccoli (sulforaphane), to test whether breast cancer stem cells would be able to grow and form tumors. These experiments provide further evidence that supports the anti-cancer properties of eating broccoli. (Read More Here) Sulforaphane is just one [...read more...]

Share
 
Smoking increases the risk in breast cancer survivors for developing a new breast cancer

In a study (presented at the May 2010 meeting of the American Radium Society) investigators report the results of their analysis of 796 breast cancer survivors who smoked after their treatment for breast cancer. All of these patients received lumpectomy (with or without radiation therapy). The authors found that the rate of developing a new breast cancer (in either the same or opposite breast) and any new cancer was significantly higher in this group of smokers compared to a non-smoking group of breast cancer survivors. (Read More Here) Integrative oncology counseling provides numerous recommendations for cancer survivors that may help to reduce [...read more...]

Share
© 2011 Integrative Oncology Essentials Suffusion theme by Sayontan Sinha